Drug Trial Radar · NCT05369767
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Nov 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
64
Actual
Start
May 24, 2022
Primary completion
Jan 30, 2023
Study completion Jan 30, 2023
Sponsor
- Lead sponsor
- Beijing Suncadia Pharmaceuticals Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- May 11, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the safety and tolerability of SHR-2004 injection in healthy subjects. In addition, this study will provide information on pharmacokinetics and pharmacodynamics of SHR-2004 injection in healthy subjects.
Conditions
- Prevention of Arterial and Venous Thrombosis
Interventions
SAD, SHR-2004Drug
Ascending dose
SAD, SHR-2004 placeboDrug
Ascending dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the number of subjects with adverse events (AEs) and serious adverse events (SAEs)Time frame: up to day 113
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Affiliated Drum Tower Hospital of Nanjing University Medical school
Nanjing, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.